Russia names new COVID-19 vaccine 'Sputnik V' in reference to Cold War space race | Inquirer ºÚÁÏÉç

ºÚÁÏÉç

Russia names new COVID-19 vaccine ‘Sputnik V’ in reference to Cold War space race

/ 07:22 PM August 11, 2020

MOSCOW– Russia has named its first approved COVID-19 vaccine ‘Sputnik V’ for foreign markets, a reference to the world’s first satellite and what Moscow sees as its success at becoming the first country to approve a vaccine, a top official said on Tuesday.

Kirill Dmitriev, head of the country’s RDIF sovereign wealth fund, said Russia had already received requests from more than 20 countries for 1 billion doses of its newly-registered COVID-19 vaccine.

He was speaking after President Vladimir Putin announced the approval after less than two months of human testing.

The speed at which Russia is moving to roll out the vaccine has prompted some international scientists to question whether Moscow is putting national prestige before solid science and safety.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

For more news about the novel coronavirus click
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this

EDITORS' PICK
usa
globalnation
business
sports
business
entertainment
www
www
globalnation
business
business
TAGS: COVID-19, Health, Russia, Sputnik V, vaccine

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2024 ºÚÁÏÉç | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.